New and Revised FDA Import Alerts for Jan. 2
On Jan. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-39: Imported Food Products that appear to be Misbranded (here)
- 89-17: Medical Devices that appear to be Adulterated because their quality falls below that which they Purport or are Represented to Possess (here)
- 66-79: Drugs from Foreign Establishments Refusing FDA Inspection (here)
- 66-41: Unapproved New Drugs Promoted in the U.S. (here)
- 66-40: Drugs from firms which have not met Drug Good Manufacturing Practices (GMPs) (here).